Supernus Pharmaceuticals, Inc. (SUPN)
USD 35.46
(-2.1%)
USD 35.46
(-2.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 111.08 Million | 116.82 Million | 127.12 Million | 138.39 Million | 143.12 Million | 128.98 Million |
| Net Income | 1.31 Million | 60.71 Million | 53.42 Million | 126.95 Million | 113.05 Million | 110.99 Million |
| Depreciation & Amortization | 84.85 Million | 85.54 Million | 32.59 Million | 18.14 Million | 6.65 Million | 7.06 Million |
| Deferred income taxes | -25.71 Million | -26.32 Million | -4.99 Million | 568 Thousand | -5.83 Million | -4.16 Million |
| Stock-based compensation | 26.75 Million | 17.56 Million | 17.91 Million | 16.56 Million | 14.84 Million | 11.29 Million |
| Change in working capital | -9.13 Million | -24.24 Million | 3.57 Million | -36.51 Million | 613 Thousand | -4.73 Million |
| Other non-cash items | 33 Million | 3.57 Million | 24.62 Million | 12.69 Million | 13.78 Million | 8.54 Million |
| Investing Cash Flow | 268.72 Million | -216.66 Million | -81.91 Million | -34.69 Million | -157.92 Million | -413.48 Million |
| Investments in PPE | -551 Thousand | -412 Thousand | -2.04 Million | -3.44 Million | -2.73 Million | -844 Thousand |
| Acquisitions | -269.28 Million | -14 Thousand | -311.69 Million | -313.54 Million | - | - |
| Investment purchases | -101.62 Million | -406.99 Million | -311.57 Million | -95.89 Million | -409.7 Million | -491.65 Million |
| Sales/Maturities of investments | 370.9 Million | 190.73 Million | 530.5 Million | 378.42 Million | 253.17 Million | 79.82 Million |
| Other Investing Activities | 269.28 Million | 14 Thousand | 12.88 Million | -241 Thousand | 1.34 Million | -809 Thousand |
| Financing Cash Flow | -397.88 Million | -10.47 Million | -130.42 Million | 3.55 Million | 3.92 Million | 376.43 Million |
| Debt repayment | -402.5 Million | - | -138.31 Million | -802 Thousand | - | -299.16 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.99 Million | - | - | - | - | - |
| Common Stock Issuance | 6.61 Million | 12.42 Million | 7.09 Million | 4.36 Million | 3.92 Million | 11.58 Million |
| Other Financing Activities | -1.99 Million | -22.9 Million | 800 Thousand | 3.55 Million | 3.92 Million | 364.85 Million |
| Accounts receivables | 18.76 Million | -16.36 Million | 3.86 Million | -34.6 Million | 15.75 Million | -35.85 Million |
| Accounts payables | -36.28 Million | -19.16 Million | 18.17 Million | 8.27 Million | 6.96 Million | -3.57 Million |
| Inventory | 6.11 Million | -17.85 Million | -14.58 Million | -10.12 Million | -969 Thousand | -9.35 Million |
| Other working capital | 2.27 Million | 29.14 Million | -3.89 Million | -56 Thousand | -21.13 Million | 44.05 Million |
| Cash at beginning of period | 93.12 Million | 203.43 Million | 288.64 Million | 181.38 Million | 192.24 Million | 100.3 Million |
| Cash at end of period | 75.05 Million | 93.12 Million | 203.43 Million | 288.64 Million | 181.38 Million | 192.24 Million |
| Capital Expenditure | -551 Thousand | -412 Thousand | -2.04 Million | -3.44 Million | -2.73 Million | -844 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -18.06 Million | -110.31 Million | -85.2 Million | 107.25 Million | -10.86 Million | 91.94 Million |
| Free Cash Flow | 110.53 Million | 116.41 Million | 125.08 Million | 134.95 Million | 140.39 Million | 128.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 38.49 Million | 19.91 Million | 124 Thousand | 1.17 Million | 1.31 Million | -15.97 Million |
| Depreciation & Amortization | 22.6 Million | 20.7 Million | 20.74 Million | 21.67 Million | 84.85 Million | 21.85 Million |
| Deferred income taxes | -6.46 Million | -8.11 Million | -5.48 Million | -10.45 Million | -25.71 Million | -9.26 Million |
| Stock-based compensation | 7.67 Million | 6.55 Million | 5.89 Million | 6.44 Million | 26.75 Million | 7.92 Million |
| Change in working capital | -10.96 Million | -2.9 Million | 13.86 Million | 1.97 Million | -9.13 Million | 29.67 Million |
| Other non-cash items | 2.16 Million | 58.95 Million | 42.21 Million | 24.14 Million | 33 Million | 1.67 Million |
| Investing Cash Flow | -77.01 Million | -48.59 Million | -51.62 Million | -65.98 Million | 268.72 Million | 34.63 Million |
| Investments in PPE | -200 Thousand | -64 Thousand | -248 Thousand | 36 Thousand | -551 Thousand | -150 Thousand |
| Acquisitions | - | - | - | - | -269.28 Million | - |
| Investment purchases | -224.92 Million | -123.98 Million | -193.7 Million | -101.62 Million | -101.62 Million | - |
| Sales/Maturities of investments | 148.1 Million | 75.45 Million | 142.32 Million | 35.6 Million | 370.9 Million | 34.78 Million |
| Other Investing Activities | 9000.00 | -48.53 Million | -51.37 Million | 1.00 | 269.28 Million | 34.78 Million |
| Financing Cash Flow | 3.07 Million | 1.65 Million | 1.57 Million | 1.09 Million | -397.88 Million | -230 Thousand |
| Debt repayment | - | - | - | -495.5 Million | -402.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 1.34 Million | -1000.00 | -1.34 Million | -1.99 Million | -1.99 Million | -230 Thousand |
| Common Stock Issuance | 3.46 Million | 1.65 Million | 2.91 Million | 3.08 Million | 6.61 Million | -230 Thousand |
| Other Financing Activities | -1.72 Million | -1000.00 | -1.34 Million | -1.99 Million | -1.99 Million | 230 Thousand |
| Accounts receivables | 7.08 Million | -4.76 Million | -3.57 Million | -2.39 Million | 18.76 Million | -5.2 Million |
| Accounts payables | -11.82 Million | -12.78 Million | 10.01 Million | -269 Thousand | -36.28 Million | -6.08 Million |
| Inventory | 4.6 Million | 6.02 Million | 1.99 Million | 5.02 Million | 6.11 Million | 6.91 Million |
| Other working capital | -14.05 Million | 8.62 Million | 5.43 Million | -395 Thousand | 2.27 Million | 34.05 Million |
| Cash at beginning of period | 52.08 Million | 63.4 Million | 75.05 Million | 94.98 Million | 93.12 Million | 24.7 Million |
| Cash at end of period | 31.67 Million | 52.08 Million | 63.4 Million | 75.05 Million | 75.05 Million | 94.98 Million |
| Capital Expenditure | -200 Thousand | -64 Thousand | -248 Thousand | 36 Thousand | -551 Thousand | -150 Thousand |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | -20.41 Million | -11.31 Million | -11.65 Million | -19.93 Million | -18.06 Million | 70.27 Million |
| Free Cash Flow | 53.32 Million | 35.56 Million | 38.15 Million | 44.99 Million | 110.53 Million | 35.72 Million |
GMEXICOB
3236
IVFH
KG
FORCEMOT
1929